Table of Contents
• Osteosarcoma overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Osteosarcoma Market
• Global Epidemiology of Osteosarcoma Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Osteosarcoma Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Osteosarcoma (2013-2023)
• Table 7: Osteosarcoma Global Market (USD Millions), (2013-2015)
• Table 8: Osteosarcoma Global Market (USD Millions), (2016-2023)
• Table 9: Osteosarcoma US Market (USD Millions), (2013-2015)
• Table 10: Osteosarcoma US Market (USD Millions), (2016-2023)
• Table 11: Osteosarcoma Germany Market (USD Millions), (2013-2015)
• Table 12: Osteosarcoma Germany Market (USD Millions), (2016-2023)
• Table 13: Osteosarcoma United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Osteosarcoma United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Osteosarcoma France Market (USD Millions), (2013-2015)
• Table 16: Osteosarcoma France Market (USD Millions), (2016-2023)
• Table 17: Osteosarcoma Italy Market (USD Millions), (2013-2015)
• Table 18: Osteosarcoma Italy Market (USD Millions), (2016-2023)
• Table 19: Osteosarcoma Spain Market (USD Millions), (2013-2015)
• Table 20: Osteosarcoma Spain Market (USD Millions), (2016-2023)
• Table 21: Osteosarcoma Japan Market (USD Millions), (2013-2015)
• Table 22: Osteosarcoma Japan Market (USD Millions), (2016-2023)
• Table 23: Osteosarcoma ROW Market (USD Millions), (2013-2015)
• Table 24: Osteosarcoma ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Osteosarcoma Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Osteosarcoma (2013-2023)
• Figure 3: Osteosarcoma Global Market (USD Millions), (2013-2015)
• Figure 4: Osteosarcoma Global Market (USD Millions), (2016-2023)
• Figure 5: Osteosarcoma US Market (USD Millions), (2013-2015)
• Figure 6: Osteosarcoma US Market (USD Millions), (2016-2023)
• Figure 7: Osteosarcoma Germany Market (USD Millions), (2013-2015)
• Figure 8: Osteosarcoma Germany Market (USD Millions), (2016-2023)
• Figure 9: Osteosarcoma United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Osteosarcoma United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Osteosarcoma France Market (USD Millions), (2013-2015)
• Figure 12: Osteosarcoma France Market (USD Millions), (2016-2023)
• Figure 13: Osteosarcoma Italy Market (USD Millions), (2013-2015)
• Figure 14: Osteosarcoma Italy Market (USD Millions), (2016-2023)
• Figure 15: Osteosarcoma Spain Market (USD Millions), (2013-2015)
• Figure 16: Osteosarcoma Spain Market (USD Millions), (2016-2023)
• Figure 17: Osteosarcoma Japan Market (USD Millions), (2013-2015)
• Figure 18: Osteosarcoma Japan Market (USD Millions), (2015-2023)
• Figure 19: Osteosarcoma ROW Market (USD Millions), (2013-2015)
• Figure 20: Osteosarcoma ROW Market (USD Millions), (2016-2023)
【掲載企業】
• Advaxis Inc.
• Amgen Inc.
• Astellas Pharma Inc.
• AVEO Pharmaceuticals Inc.
• Bayer AG
• Bellicum Pharmaceuticals Inc.
• Celgene Corporation
• Celldex Therapeutics Inc.
• CytRx Corporation
• Ipsen S.A.
• Karyopharm Therapeutics Inc.
• Merck & Co. Inc.
• Merrimack Pharmaceuticals Inc.
• NantKwest Inc.
• Novartis AG
• Tesaro Inc.
【レポートのキーワード】
骨肉腫
【免責事項】
https://www.marketreport.jp/reports-disclaimer